Wells Fargo analyst Stephen Baxter raised the firm’s price target on Molina Healthcare (MOH) to $208 from $165 and keeps an Overweight rating on the shares. For managed care organizations, the firm is most constructive on Medicare Advantage with uncertainty high for Medicaid/Exchanges. Wells sees a more difficult backdrop for hospitals in 2026 as post-COVID tailwinds wane and legislative risks near. Distributor debate remains revisions vs. multiples.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Trump says he will meet with 14 health insurers in a few days
- Molina Healthcare price target raised to $224 from $182 at Bernstein
- Molina Healthcare price target lowered to $175 from $190 at Truist
- Molina Healthcare price target raised to $164 from $144 at Barclays
- Early notable gainers among liquid option names on December 31st
